Results of animal studies suggest a nonlinear dose-response relationship for benzene effects. by Parodi, S et al.
Environmental Health Perspectives
Vol. 82, pp. 171-176, 1989
Results of Animal Studies Suggest a
Nonlinear Dose-Response Relationship for
Benzene Effects
by S. Parodi,* W. K. Lutz,t A. Colacci,t M. Mazzullo,t
M. Taningher,* and S. Grillit
Considering the very large industrial usage ofbenzene, studies in risk assessment aimed at the evaluation
ofcarcinogenic risk at low levels ofexposure are important. Animal data can offer indications about what
could happen in humans and provide more diverse information than epidemiological data with respect to dose-
response consideration. We have considered experiments investigating metabolism, short-term genotoxic-
itytests, DNAadductformation, andcarcinogenicity long-term tests. Accordingtothe differentexperiments,
a saturation ofbenzene metabolism and benzene effects in terms ofgenotoxicity seems evident above 30 to
100 ppm. Below 30 to 60ppm the initiating effect ofbenzene seems to be linear for a large interval ofdosages,
at leastjudgingfrom DNAadduct formation. Potential lackofapromotingeffect ofbenzene (below 10ppm)
could generate asublinear response at nontoxic levels ofexposure. This possibility was suggested by epidemio-
logical data in humans and is not confirmed or excluded by our observations with animals.
Introduction
Benzene is one ofthe chemicals with the largest indus-
trial production in the world. Production ofbenzene ofall
grades in 1980inthe U.S. totaled more than 5million tons
(1). Millions oftons ofbenzene were also produced in Eu-
rope, the USSR, and Japan. Because of its presence in
manyfuels and as a contaminant in many organic chemi-
cals and solvents, ithasbeen estimated that in 1980 about
2 million workers were potentially exposed by benzene
in the U.S. alone (1).
As is reasonable to expect, epidemiological data show
very small tumorincidences atlowlevels ofexposure (for
instance clearly below 30 ppm of average exposure dur-
ing aworking day). Most epidemiological evidence seems
to concern levels of exposure roughly in the order of30
ppm and higher (2). In a very recent paperby Rinsky et
al. (3), an attempt was made to investigate the relative
risk in humans forlevels of exposure lower than 10 ppm
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over a40-yearworking lifetime. Only three to four cases
in excess ofthe number expected were observed in this
low range. In this situation it is difficult to establish, on
the basis of epidemiological data alone, a type of dose-
response relationship allowingextrapolations oftumorin-
cidences at 10 ppm or 1 ppm (average exposure during
a work day).
We were interested in investigating the situation in
small rodents. For small rodents, data are available that
can allow the construction ofdose-response relationships
for several types of parameters: production of metabo-
lites, formation of DNA adducts, response to tests of
genotoxicity, [chromososmal damage, micronuclei induc-
tion, induction ofsisterchromatidexchanges (SCEs)], and
also long-term experiments of carcinogenicity.
Formation ofmetabolites, formation ofDNA adducts,
and response to tests of genotoxicity give information
mainly aboutthe initiatingpotential ofbenzene. Whentu-
morformation inlong-term experiments is examined, we
see the effects ofbenzene both on initiation and promo-
tion. Toxicity (for instance, bone marrow toxicity) and
compensatory cell regeneration could have a significant
promoting effect. Unfortunatelswe were unable to find
studies that investigated the pure promoting activity of
benzene.
In spite ofthe lack ofinformation about the promoting
activity of benzene, the animal data about benzene re-
main much richer than epidemiological data; in particu-
lar, many more observations are possible about dose-PARODI ET AL.
response relationships. In this paper we have tried to in-
vestigate at different levels of exposure animal data
about benzene, specifically in the perspective of what
these data can suggest in terms ofdose-response relation-
ships. As ageneral trend, the results seem to point in the
direction of a saturation of metabolism and probably of
the initiating potential of benzene above 30 to 50 ppm.
This could confirm some epidemiological data concerning
high levels of exposure.
Epidemiological Data
It is difficult to establish a dose-response relationship
between level, frequency, and duration of benzene ex-
posure and increased risk ofleukemia. Three papers are
available, dealingwith similarlevels ofexposure and simi-
lar levels of increased risk. In a paper by Ott et al. (4)
workers were exposed to ranges between 1 and 30 ppm
ofbenzene (per work day) for approximately 8 to 9 years.
This gave a relative risk ofmyelogenous leukemia of3.75.
In a paper by Rinsky et al. (3) cases were exposed to
an average of 24 ppm of benzene per work day for an
average duration of8.7 years. The standardized mortal-
ity ratio for leukemia was 3.37. In a paper by Yin et al.
(5) cases were exposed to a median value of28.4 ppm per
work day for an average time that can be roughly esti-
mated around 9 years. The standardized mortality ratio
for leukemia was 5.74.
It is difficult to normalize completely data from differ-
ent papers, and the concordance among the data from the
three different papers that we havepreviously mentioned
can already be considered rather good.
In a paper by Vigliani (6), higher levels of exposure
were considered. Cases were exposed to 200 to 500 ppm
of benzene per work day for an average length of ex-
posure of about 16 years. According to the author, the
risk ofleukemia was at least 20 times higher than for the
general population. Because in this case the level of ex-
posure was at least 10 times the level of exposure
reported in the three previous works and the length of
exposure was about twice, we could expect arelative risk
much higher than 20 (perhaps around 50-90). It is diffi-
cult to say ifthis nonlinearrelationship reflects a flatten-
ing out ofthe response above 30 ppm and 8 years of aver-
age length of exposure, or if it is simply related to an
imperfect compatibility of the data.
What about levels ofexposure below 30 ppm per work-
ing day? Rinsky et al. (3) have suggested that below the
equivalent of 10 ppm over a40-year workinglifetime, the
dose-response relationship could be sublinear. The num-
ber of cases on which this suggestion is based is too small
to reach a clear statistical significance; however, in our
opinion, this suggestion is intriguing for thefollowing rea-
son. It has been observed by Yin et al. (5) that leukemia
mortality among benzene poisoning cases was 49 times
that in benzene workers.
It is quitepossible that cell death and compensatory cell
regeneration in bone marrow cells could have a promot-
ingeffect inbenzene leukemogenesis. Ifbenzene is a com-
plete carcinogen because it is endowed with both initiat-
ing and promoting activity, the combination of the two
effects could generate the type ofcurve hypothesized by
Rinsky et al. (3) in the low range ofbenzene exposure.
In summary, the dose-response of the leukemia inci-
dence curve for benzene could be a sigmoid curve that
flattens out atlevels ofexposure above 50 to 100ppm per
work day and is perhaps sublinear at levels ofexposure
below 10 to 30 ppm (Table 1).
Metabolism of Benzene in Rodents
The dose-response relationship for benzene metabolism
seems to depend, as is reasonable to expect, on the level
of exposure. Jongeneelen et al. (7) have exposed male
Wistar rats for 8 hr to inhalation of0, 7.5, 10, 13, 21, and
33 ppm ofbenzene. S-Phenyl-N-acetyl-cysteine and phe-
nol were determined in the 24-hr urine of the exposed
rats. The dose-response relationship was linear for both
metabolites, suggesting that in rats, nonsignificant satu-
ration ofbenzene metabolism is present for a level ofin-
halation exposure lower than 30 ppm.
The situation seems to be different forhigher levels of
exposure. Ulanova and Avilova (8) have shown that the
content ofphenol in the urine ofrats after a single 4-hr
inhalation exposure increases much more slowly than the
exposure level for levels of exposure above 100 mg/m3
('--30ppm), suggesting aprogressive saturation ofmetab-
olism above this concentration. Similarly, Grilli et al. (9)
have found, using a closed inhalation chamber, that me-
tabolism ofbenzene in the chamber followed essentially
zero-order kinetics above 50 ppm (at equilibrium between
rat and chamber), and first-order kinetics below 50 to 30
ppm. Zero-order kinetics is equivalent to saturation of
metabolism.
In a different experiment, ratsexposed for 6 hr toben-
zene concentrations of 125, 250, 625, or 1250 ppm ex-
creted similar amounts of phenol in urine (10). Even in
this experiment benzene metabolism was already satu-
rated above 100 ppm.
Sabourin et al. (11) showed an increased amount ofun-
metabolized benzene in air above 130 ppm in B6C3F1
mice and F344/N rats after 6-hr inhalation exposure. To-
tal production ofmetabolites in urine and feces was also
evaluated. Saturation ofmetabolism was moremarkedin
mice than in rats, mainlybecause absorption washigher
in mice than in ratsbecause ofincreased ventilation. The
Table 1. Summary ofquantitative epidemiological data available
for human occupational exposure to benzene.
Level of Dose-response
exposure Relative risk relationship
Around 3 ppm, about Linear or
8 years of exposure (3) 1.4 sublinear
Around 30 ppm, 8-9
years of exposure (3-5) 3-6 Linear
Around 200-500 ppm,
about 16 years of
exposure (6) 20 Supralinear?
172DOSE-RESPONSE OF BENZENE EFFECTS




Up to 30 ppm Linear (D)
30 ppm and above Supralinear (8)
30-50 ppm and above Supralinear (9)
Above 100 ppm Supralinear (10)
Above 130 ppm Supralinear (11)
same authors (11) reported a saturation of benzene me-
tabolism after administration by gavage in both rats and
mice for dosages above 50 mg/kg.
In conclusion, benzene metabolism seems to be satu-
rated in rodents at the highest concentrations. Saturation
seems to start most probably at 30 to 50 ppm (Table 2).
Short-Term Tests
Mazzullo et al. (12) have investigated the dose-response
relationship for DNA adducts in rats after IP acute ad-
ministration. Liver, kidney, lung, stomach, and spleen
were investigated. The range ofdosagesexplored wasbe-
tween 1.04 x 10 -6and 6.23 mmole/kg. The dose-response
relationship in liver was strikingly linearfrom the lowest
dosage up to 0.623 mmole/kg. A flattening out ofthe re-
sponse appeared at the highest dosage.
Grilli et al. (9) have examined the response to benzene
in 180 different experiments investigating the genotox-
icity of benzene. The main categories of these tests of
genotoxicity were DNA damage and repair, mutations,
and chromosomal anomalies, including SCEs.
While tests ofmutagenicity were positive in only 24%
of the cases, tests related to chromosomal alterations
were positive in 76% ofthe cases. It has been suggested
by Ashby et al. (13)thatwhenlarge numbers oftests are
consideredfor agiven chemical, a20% ofpositive results
is more typical of a negative compound and 80% ofposi-
tive resultsis more typical ofaclearlypositive compound.
Therefore we have assumed that most typically benzene
clearly shows itsgenotoxicity at the chromosomal level.
Especially, it is very common to find positive results for
the induction of micronuclei, chromosome aberrations,
and SCEs in rodents after treatment with benzene.
For several experiments concerningmicronuclei, chro-
mosome aberrations, and SCEs, we were able to inves-
tigate the dose-response relationship. The results are
reported in Table 3. While the experiments considered
all seem to suggest aflatteningoutofthe response toben-
zene between 10 and 100 ppm, bothformicronuclei induc-
tion, chromosomal anomalies, and SCEs, a paper which,
to some extent, disagreedwith suchfindings wasrecently
published (14). In that paper, the induction ofchromatid
breaks in lymphocytes ofmice after subehronic exposure
to benzene was investigated. Mice were treated daily by
gavage with 0, 36.6, 73.2, and 146.4 mg/kgofbenzene for
2 weeks. Judgingfrom the graph shown by the authors,
the response was essentially linear. According to EPA
computations (15,16), 146.4 mg/kg corresponds roughly to
42 ppm/day. The animals used were Swiss ICR male
mice. It is difficult to say ifthe linear response was spe-
cifically related to the strain used or if aflattening out of
the response would have appeared above 40 ppm.
If we accept the idea that the majority of the results
Table 3. Dose-response relationship for the clastogenic activity ofbenzene in rodents.
Route of Effecta/dosage ratio at different dosage
Species administration End point and dose unit Low Medium High
Male Swiss Oralb Micronuclei/1000 PCE,C
mice mg/kg 4-2.4/8.8d= 0.18 6-2.4/88 = 0.04 28.7-2.4/880 = 0.03
Oralb Chromosome aberrations
per metaphase, mg/kz 0.06-0.03/8.8d = 0.0034 0.16-0.03/88 = 0.0015 1.1-0.03/880 = 0.0012
Male B6C3F, Orale Micronuclei/1000 NCE,
mice mg/kg 2.5-1.2/25g = 0.052 5.8-1.2/100 = 0.046 9.3-1.2/600 = 0.013
Male Wistar Inhalationh % Cells with chromosome
rats anomalies, ppm 6 hr 3.03-1.54/10 = 0.15 4.45-1.54/100 = 0030 7.81-1.54/1000 = 0.0063
Male DBA/2 Inhalation' SCE/metaphase,
mice ppm 6 hr 7.6-5.9/10 = 0.17 9.5-5.9/100 = 0.036 13.8-5.9/1000 = 0.0079
Inhalation' Micronuclei/1000 PCE,
ppm 6 hr 9-2.1/10 = 0.67 20.3-2.1/100 = 0.18 28.1-2.1/1000 = 0.026
Sprague-Dawley Inhalation' SCE/metaphase,
rats ppm 6 hr 10.4-8.6/10 = 0.18 11.1-8.6/30 = 0.083
Sprague-Dawley Inahalation' Micronuclei/1000 PCE,
rats ppm 6 hr 6.2-2.0/10 = 0.42 7.6-2.0/30 = 0.19
aTreated values minus control values.
bTwo doses were administered 24 hr apart and animals were sacrificed 30 hr after the first dose (30).
CPCE, polychromatic erythrocytes.
dCorresponding to 3.76 ppm according to EPA computations (15) assuming a respiratory absorption coefficient of0.5 and a ventilation capacity
of 0.03 L/min for the mouse (16).
'Subchronic treatment within NTP study (25). Micronuclei were measured after exposure for 5 days/week for 4 months (31).
fNCE, normochromatic erythrocytes.
gCorresponding to 10.7 ppm according to EPA computations (15), assuming a respiratory absorption coefficient of0.5 and a ventilation capacity
of 0.03 L/min for the mouse (16).
hExposure of 6 hr (32).
'Exposure of 6 hr (33).
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at the level ofchromosomal damage seem to suggest, in
the case ofbenzene, aflatteningoutoftheresponse above
30 ppm, we have to show that there are other direct-
acting compounds that generate a linear response over
a larger interval than the interval ofresponse observed
here. This control isneeded torule outthepossibilitythat
the responses observed are intrinsically nonlinear in the
range under scrutiny even for direct-acting compounds.
Neal and Probst(17)have investigated the induction of
SCEs invivo in hamsterbone marrow cells. Averygood
linear response was observed for mitomycin C (MMC)
over the whole range ofdosages examined and up to 37
SCEs per metaphase. Linear responses were also ob-
servedfor several othercompounds like N,N',N"-triethyl-
enethiophosphoramide, hycanthone, busulfan, and
triethylene melamine with up to 31 SCEspermetaphase.
Only cyclophosphamide, which is known to require meta-
bolic activation, showed a nonlinear dose response. Car-
rano et al. (18) have shown in vitro in CHO cells a very
good linear response for MMC and ethyl methanesul-
fonate (EMS)up to more than 50 SCEs per cell. Because
in our results (Table 3) the number of SECs per
metaphase never exceeded 15, the flattening out ofthe
response cannotbe considered intrinsic to SCE behavior,
butcanbe reasonably attributedto the saturation ofben-
zene metabolism.
Kliesch et al. (19) have examined the induction of
micronuclei invivo inbone marrow cells aftertreatment
with doubling dosages of methyl methanesulfonate
(MMS), MMC, andprocarbazine (PC). The response was
clearly linear for both MMS and MMC with up to 70 to
80 micronuclei per 1000 polychromatic erythrocytes
(PCEs). Only for PC, which required metabolic activa-
tion, was a flattening out of the response observed.
Similar results have been reported by Aeschbacher
(20). The number of micronuclei per 1000 PCEs was
studied in several inbred strains of mice. N-Methyl-
N'-nitro-N-nitrosoguanidine (MNNG), MMC, and MMS
were investigated. For all three compounds tested, and
essentially in all the strains examined, micronuclei gave
a linear response with up to 20 micronuclei for MMNG,
up to 100 micronuclei for MMC, and up to 50 micronuclei
for MMS.
Similar linear responses were also obtainedfor the in-
duction ofmicronuclei in vitro. Bonatti et al. (21) exam-
ined the induction ofmicronuclei in V79 cells. Both ethyl
nitrosourea (ENU) and EMS induced a linear response
up to 100 micronuclei per 1000 cells.
Lasne et al. (22) also examined the induction of
micronuclei in V79 cells. MNNG, MMS, and EMS were
examined only at low concentrations. The response was
perfectly linear for MNNG and EMS and almost linear
for MMS. However, only up to 10 to 15 micronuclei per
1000 cells were induced atthelow concentrations tested.
Ifwe consider that we observed aflattening out ofthe
induction ofmicronuclei in response to benzene for num-
ber ofmicronuclei below 10/1000 cells, asreported in Ta-
ble 3, it appears thatthis saturation ofthe response is not
intrinsic to themicronuclei indication butratherbecause
ofthe metabolic activation ofbenzene. We have to under-
line that to showthe intrinsically linearresponse ofSCE
andmicronucleus induction overasufficientlylargerange
we didnotperform any selectionwhatsoeverofthe avail-
able literature, butjustused the first six suitable papers
available in our files.
Carcinogenicity in Animals
Several studies have shown that benzene is a carcino-
geninmice andrats(23-27). Differentorgansare affected
butleukemias are notparticularly prominent and are not
usually ofthe myeloidtype. While the main targetorgan
seems to be different in humans and rodents, oncogenic
potency seems to be similar in both species.
Grilli et al. (9) have discussed in detail the notion that
the ratio oftumorlatency to life-span is asafirstapprox-
imation similar in humans and rodents. Assuming that
this is so, fromthe data ofMaltoni et al. (26)we can make
the extrapolation that 100ppm, 8 hr/day, 5 days aweek,
for 2 years, will induce an overall tumor incidence of
111/1000 rats over controls.
By applying a similar extrapolation to the data of
Snyder et al. (24), we obtain an overall tumor incidence
of67/1000 mice over controls (9). It has been estimated
bythe IARCWorkingGroup(2)thatinhumans, 100ppm
ofbenzene over a45-year-workinglifetime would include
140 to 170 cases ofleukemia per 1000 exposed workers.
The orderofmagnitude ofriskestimations inrodents and
humans appears to be very similar, especially consider-
ingthat carcinogenic potencies can span a range ofmore
than 107 times (28,29).
Ifthe quantitative dimension ofthe phenomenon oftu-
morinduction is similar in humans androdents, it can be
interesting to look at the dose-response relationship of
cancer incidence in rodents. This dose-response relation-
ship is analyzed in Table 4. This table seems to suggest
that above 25 ppm [approximate transformation in parts
per million for rats according to (15,16)] cancer incidence
increases less than proportionally to the dosage. Onco-
genic potency index (OPI), which is essentially incidence
dividedby dosage, seems to decrease by aboutfive times
whenthe dosage is increasedfrom about25 to about250
ppm.
In conclusion, atleastthegavage experiments reported
in Table 4, forwhich several dosages are available, seem
to suggest a possible saturation ofbenzene metabolism
for the highest dosages. No dose-response relationships
were available for inhalation experiments.
Discussion
We have seenthat several dataconcerningtheproduc-
tionandexcretionofbenzenemetabolitesinrodents seem
to suggest some saturation ofmetabolismforlevelsofex-
posure above 30 to 50 ppm. Except for one paper show-
inglinearity upto the equivalent of40ppm, all thepapers
concerning the genotoxicity of benzene (chromosome
anomalies, SCEs, and micronuclei) showed a flattening
outoftheresponse startingatlevelsofexposurebetween
30 and 100 ppm.
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Table 4. Oncogenic potency in rodents for different dosages of benzene.
Equivalent dosage, ppm pro die,
Dosage, mg/kg 24-hr inhalationa Oncogenic potency indexb
pro die, gavage Rats Mice F344 rats (25)C B6C3F1 mice (25) S-D rats (26)
25 27 7 1.14 0.88
50 53 14 0.82 0.56
100 107 29 0.59 0.53
200 214 57 0.49
250 267 71 0.23
500 534 143 0.16
aAccording to Lee et al. (15) and Gold et al. (16).
bOncogenic potency index as afunction ofdosage ofbenzene in mice and rats = - Ln(1 -1)IDt, where Iisthe excessincidence overcontrols(proportion
of animals with at least one malignant tumor for all tumors), t is the length of observation (time unit = 2 years), and D is the dosage in millimole
per kilogram per day equivalent to the total dose divided by a 2-year exposure (28). Only dosages which produced statistically significant effects
(p < 0.05) were considered.
cNumbers in parentheses are references.
In a paper by Mazzullo et al. (12), DNA adduct forma-
tion was explored for a very large range ofdosages, from
6.23 x 10-6to 6.23 mmole/kg. Saturation ofmetabolism
started at the equivalent of 60 ppm, and it was evident
only in some tissues and macromolecules.
Below 60ppm the datawereremarkable forthe linear-
ity of the dose-response relationship. In three different
experiments in rats and mice, in which benzene was ad-
ministered chronically by gavage and long-term car-
cinogenicity wasinvestigated, aflattening outofthe dose-
response relationship was apparent at dosages equivalent
to 30 to 50 ppm and above.
Three different epidemiological investigations concern-
ing levels ofexposure around 30 ppm per work day, for
an average length ofexposure ofabout 8 to 9 years, are
quite consistent in suggesting arange ofrelative riskbe-
tween three and six. In a paper by Vigliani (6), higher
levels and durations ofexposure are considered and some
flattening out ofthe dose-response relationship seems ob-
servable.
In a paper by Rinsky et al. (3), levels of exposure be-
low 10ppmperworking day are also considered, and the
few data available suggest an interesting sublinear re-
sponse. As shown by Yin et al. (5), the risk ofleukemia
is very much increased when benzene toxicity ispresent.
This observation suggests apromotingeffect ofbenzene
that could also explain the sublinear dose-response
reported by Rinsky et al. (3)forlevels ofexposure below
10 ppm. Indeed, below 10 ppm the promoting effect
related to benzene toxicity and compensatory cell
regeneration ofbone marrow cells could presumably be
almost negligible.
In summary, from DNAadduct data, we have evidence
that the preliminary step ofinitiation probably displays
alinear dose-response relationship evenforvery lowben-
zene dosages. Above 30 to 50 ppm, metabolism and
genotoxicity data suggest aflattening out ofthe initiation
response. This flattening out ofthe initiation response is
alsoprobably detectable inlong-term carcinogenicity ex-
periments in rodents and perhaps also in the epidemio-
logical data of Vigliani (6).
Below 10 ppm it could be reasonable to assume a
negligible promoting effect of benzene (especially a
negligible clonal expansion ofinitiated clones). This could
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FIGURE 1. Possible dose-response relationship for benzene at different
levels of exposure in humans. Solid and dashed line: assumed be-
haviourofbenzene. Dotted line: linear dose-response relationship on
semilog paper.
Rinsky et al. (3). A possible final synthesis of the situa-
tionis shown in Figure 1. The effect ofbenzene is repre-
sentedby a sigmoid curve, sublinear below 10 to 30 ppm
and flattened above 50 to 100 ppm.
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